Barbara Leyman

Insider Reports History

Location
C/O Sutro Biopharma, Inc., 111 Oyster Point Boulevard, South San Francisco, CA
Signature
/s/ David Pauling as attorney-in-fact for Barbara Leyman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Barbara Leyman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SUTRO BIOPHARMA, INC. Chief Business Officer Restricted Stock Units (RSUs) 75K $115K $1.36 Jul 8, 2025 Direct
SUTRO BIOPHARMA, INC. Chief Business Officer Common Stock 16.1K $12.5K $0.78 Jul 8, 2025 Direct
SUTRO BIOPHARMA, INC. Chief Business Officer Stock Option (Right to Buy) 91K Apr 4, 2025 Direct

Insider Reports Filed by Barbara Leyman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STRO SUTRO BIOPHARMA, INC. Jul 8, 2025 3 -$6.98K 4 Aug 26, 2025 Chief Business Officer
STRO SUTRO BIOPHARMA, INC. Apr 4, 2025 2 $0 4 Apr 8, 2025 Chief Business Dev. Officer
STRO SUTRO BIOPHARMA, INC. Jul 8, 2024 2 $0 4 Jul 10, 2024 Chief Business Dev. Officer
STRO SUTRO BIOPHARMA, INC. Jul 8, 2024 0 $0 3 Jul 10, 2024 Chief Business Dev. Officer